University of Vermont - Larner College of Medicine- Site Number : 8400130 — Burlington, Vermont

University of Vermont - Larner College of Medicine- Site Number : 8400130 is a clinical research site located in Burlington, Vermont, United States 05405.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University of Vermont - Larner College of Medicine- Site Number : 8400130 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Vermont - Larner College of Medicine- Site Number : 8400130?

University of Vermont - Larner College of Medicine- Site Number : 8400130 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Vermont - Larner College of Medicine- Site Number : 8400130 conducted?

University of Vermont - Larner College of Medicine- Site Number : 8400130 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis.

Is University of Vermont - Larner College of Medicine- Site Number : 8400130 accredited by Crixeo Health?

University of Vermont - Larner College of Medicine- Site Number : 8400130 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Vermont - Larner College of Medicine- Site Number : 8400130?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.